Foundation for innovation
in Cardiometabolism and Nutrition

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

The New England Journal of Medicine

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Restez en contact

Recevez toute l’actualité de la fondation ICAN

This field is for validation purposes and should be left unchanged.

Nos fondateurs

CERTIFIÉ ISO 9001

Nos soutiens institutionnels

Notre réseau